SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: QuickTrade who wrote (7340)7/13/1998 12:12:00 PM
From: Due Diligence  Read Replies (2) of 8798
 
LAJD: Reporting,News out, and at the dip. Been in for a while now. Like the airline link and the Initial European Distribution order too.
Jimbo

(PR NEWSWIRE) DJ: La Jolla Diagnostics Announces Continued Growth in Distr
DJ: La Jolla Diagnostics Announces Continued Growth in Distribution and Public
Relations

LA JOLLA, Calif., July 13 /PRNewswire/ -- La Jolla Diagnostics, Inc. (OTC
Bulletin Board: LAJD) announced today that an article on the company has
just appeared in the Sun Country Airlines Magazine.
This article in the magazine, which will be exposed to 2,000,000
enplanements, is titled: LA JOLLA DIAGNOSTICS: Heading for Big Things in
Migraine Treatment? It discusses the company, the patented ClusterWater
technology used in its nutriceutic products including a product for the
possible treatment of migraine headaches.
This article follows on the heels of an announcement last week by La Jolla
Diagnostics which disclosed the conclusion of a European distribution
agreement along with a $200,000 initial purchase order.
The La Jolla Diagnostics products to be distributed include:
* Feverfew Nasal Mist(TM), a patent pending moisturizing nasal spray,
* MigraSpray(TM) a saline solution containing the herb feverfew (commonly
used as a treatment for migraine headaches) and designed to be sprayed under
the tongue,
* Living Water Eye Lotion(TM), a saline solution which cleanses and soothes
the eye without interfering with natural functions, and
* OptoPet(TM) Eye Wash for cleansing the eyes of dogs and cats and removing
mucous which causes fur stains beneath the eyes, a major problem in certain
breeds.
These products are prepared using water processed by a recently patented
technology* to form ClusterWater(TM). While remaining chemically identical
with unprocessed water, ClusterWater forms polywater complexes which enhance
the effectiveness of biological solutions.
*U.S. Patent 5711950
Distribution of La Jolla's feverfew products has recently been made more
efficient by a process which enhances heat stability.
La Jolla Diagnostics is a company engaged in the development and marketing
of diagnostic tests and consumer health care products, and the licensing of
drug delivery systems.
/CONTACT: La Jolla Diagnostics, Inc., 800-454-6790, or Fax: 619-454-7851/
09:25 EDT
*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext